Efficacy and safety of GLP-1RAs for people with obesity: A systematic review based on RCT and Bayesian network meta-analysis
Uncovering a GLP-1 receptor-independent pathway The researchers set out to understand the relationship between GLP-1 therapies and depression, specifically whether they affect the gut microbiome to modulate mood
The study data comes from Ivim Health, a leading national virtual provider of personalized medical weight management
The dual mechanism also appears to provide better preservation of lean mass during weight loss, though head-to-head comparison data is still limited
When food sits in the stomach for an extended period, it can release gases containing sulfur, leading to the distinct sulfur belching some people experience on medications like semaglutide. Mild or occasional burping after starting a GLP-1 medication is typically normal, especially as your body adjusts to the treatment
Retatrutide dosing in research settings has ranged from low starting doses up to 12 mg weekly, with gradual titration over several weeks